Home/Pipeline/MAV-002

MAV-002

Immuno‑oncology

PreclinicalActive

Key Facts

Indication
Immuno‑oncology
Phase
Preclinical
Status
Active
Company

About Maven Bio

AI‑driven biotech leveraging deep‑learning protein design to generate novel oncology and immunology therapeutics.

View full company profile

Therapeutic Areas

Other Immuno‑oncology Drugs